For the 2020-21 NBA season, BioReference has been providing testing services, utilizing PCR and rapid diagnostics, at the 30 NBA team facilities in 28 cities across the U.S. BioReference previously ...
Similar to BioReference's role as the testing provider for the MLS is Back Tournament, BioReference is providing laboratory-based PCR COVID-19 testing as well as point-of-care (rapid) COVID-19 testing ...
ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S ...
The Web cast will be archived, on both Web sites, for 30 days following the call. About Bio-Reference Laboratories, Inc. The Company is the largest independent regional clinical laboratory in the ...
BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a $704,349 government fine for medically unnecessary blood tests. The ...
The state agreed to pay BioReference Laboratories $150 million for analyzing Covid-19 diagnostic and antibody tests through July 25, according to a database of state contracts. BioReference tests the ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
Bio-Reference Laboratories is up 81 cents, or 14.6 percent, to $6.37, after the Elmwood Park, N.J., firm reaffirmed its outlook for at least a 100 percent increase in pre-tax net income and a 20 ...
BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter of Fiscal 2012 before the open of market trading on Thursday, August 30, 2012.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results